Abstract
Over the past decade, new insights into epidemiology, pathophysiology and biomarkers have modified our understanding of acute kidney dysfunction and damage, and their association with subsequent chronic kidney disease. The concept of acute kidney injury (AKI), which has relied on established but nonetheless flawed biomarkers of solute clearance (serum creatinine levels and urinary output), has been challenged by the identification of novel biomarkers of tubular stress and/or damage. The expression of some of these novel biomarkers precedes changes in conventional biomarkers or can increase their predictive power, and might therefore enhance the clinical accuracy of the definition of AKI. In addition, the need to consider AKI recurrence, duration and progression to chronic kidney disease within the clinical and epidemiological framework of AKI led to the emergence of the concept of acute kidney disease. New definitions of acute syndromes of kidney impairment and injury are needed.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
06 April 2021
A Correction to this paper has been published: https://doi.org/10.1038/s41581-021-00426-2
References
Hoste, E. A. et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 41, 1411–1423 (2015).
Kellum, J. A., Sileanu, F. E., Bihorac, A., Hoste, E. A. & Chawla, L. S. Recovery after acute kidney injury. Am. J. Respir. Crit. Care Med. 195, 784–791 (2017).
Priyanka, P. et al. The impact of acute kidney injury by serum creatinine or urine output criteria on major adverse kidney events in cardiac surgery patients. J. Thorac. Cardiovasc. Surg. https://doi.org/10.1016/j.jtcvs.2019.11.137 (2020).
Chawla, L. S., Amdur, R. L., Amodeo, S., Kimmel, P. L. & Palant, C. E. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int. 79, 1361–1369 (2011).
KDIGO, A. K. I. W. G. Kidney disease: improving global outcomes (KDIGO) clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2, 1–141 (2012).
Bellomo, R., Kellum, J. A. & Ronco, C. Defining acute renal failure: physiological principles. Intensive Care Med. 30, 33–37 (2004).
Mehta, R. L. et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit. Care 11, R31 (2007).
Ronco, C., Bellomo, R. & Kellum, J. A. Acute kidney injury. Lancet 394, 1949–1964 (2019).
Kellum, J. A. Acute kidney injury. Crit. Care Med. 36, S141–145 (2008).
Vincent, J. L. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 22, 707–710 (1996).
Desanti De Oliveira, B. et al. Molecular nephrology: types of acute tubular injury. Nat. Rev. Nephrol. 15, 599–612 (2019).
Barasch, J., Zager, R. & Bonventre, J. V. Acute kidney injury: a problem of definition. Lancet 389, 779–781 (2017).
Maynard, S. E. & Thadhani, R. Pregnancy and the kidney. J. Am. Soc. Nephrol. 20, 14–22 (2009).
Ackermann, U. Cardiac output, GFR, and renal excretion rates during maintained volume load in rats. Am. J. Physiol. 235, H670–676 (1978).
Vincent, J. L. et al. The clinical relevance of oliguria in the critically ill patient: analysis of a large observational database. Crit. Care 24, 171 (2020).
Prowle, J. R. et al. Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit. Care 15, R172 (2011).
Jin, K. et al. Intensive monitoring of urine output is associated with increased detection of acute kidney injury and improved outcomes. Chest 152, 972–979 (2017).
Kellum, J. A. et al. Classifying AKI by urine output versus serum creatinine level. J. Am. Soc. Nephrol. 26, 2231–2238 (2015).
Kaddourah, A., Basu, R. K., Bagshaw, S. M., Goldstein, S. L. & AWARE Investigators. Epidemiology of acute kidney injury in critically Ill children and young adults. N. Engl. J. Med. 376, 11–20 (2017).
Ronco, C., Bellomo, R. & Kellum, J. Understanding renal functional reserve. Intensive Care Med. 43, 917–920 (2017).
Ronco, C. & Chawla, L. S. Glomerular and tubular kidney stress test: new tools for a deeper evaluation of kidney function. Nephron 134, 191–194 (2016).
Sharma, A. et al. Optimizing a kidney stress test to evaluate renal functional reserve. Clin. Nephrol. 86, 18–26 (2016).
Husain-Syed, F. et al. Cardio-pulmonary-renal interactions: a multidisciplinary approach. J. Am. Coll. Cardiol. 65, 2433–2448 (2015).
Wesson, L. G., Jr in Physiology of the Human Kidney 96-108 (Grune and Stratton, 1969).
Glassford, N. J. et al. Interobserver agreement for post mortem renal histopathology and diagnosis of acute tubular necrosis in critically ill patients. Crit. Care Resusc. 19, 337–343 (2017).
Levin, A. S., Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl. 3, 1–150 (2013).
Kudose, S., Hoshi, M., Jain, S. & Gaut, J. P. Renal histopathologic findings associated with severity of clinical acute kidney injury. Am. J. Surg. Pathol. 42, 625–635 (2018).
Chawla, L. S. et al. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit. Care 17, R207 (2013).
Haase, M., Kellum, J. A. & Ronco, C. Subclinical AKI — an emerging syndrome with important consequences. Nat. Rev. Nephrol. 8, 735–739 (2012).
Koyner, J. L. et al. Tissue inhibitor metalloproteinase-2 (TIMP-2)IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J. Am. Soc. Nephrol. 26, 1747–1754 (2015).
Joannidis, M. et al. Use of cell cycle arrest biomarkers in conjunction with classical markers of acute kidney injury. Crit. Care Med. 47, e820–e826 (2019).
Zappitelli, M. et al. The association of albumin/creatinine ratio with postoperative AKI in children undergoing cardiac surgery. Clin. J. Am. Soc. Nephrol. 7, 1761–1769 (2012).
Ichimura, T. et al. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest. 118, 1657–1668 (2008).
Paragas, N. et al. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat. Med. 17, 216–222 (2011).
Dubin, R. F. et al. Urinary tubular injury biomarkers are associated with ESRD and death in the REGARDS study. Kidney Int. Rep. 3, 1183–1192 (2018).
US Food & Drug Administration. Review submission of the qualification of seven biomarkers of drug-induced nephrotoxicity in rats. https://www.fda.gov/media/82532/download (2008).
US Department of Health and Human Services. US Food & Drug Administration https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?ID=DEN130031 (2014).
Husain-Syed, F. et al. Persistent decrease of renal functional reserve in patients after cardiac surgery-associated acute kidney injury despite clinical recovery. Nephrol. Dial. Transpl. 34, 308–317 (2019).
Emlet, D. R. et al. Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: differential expression and secretion in human kidney tubule cells. Am. J. Physiol. Renal Physiol. 312, F284–F296 (2017).
Zarbock, A. et al. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA 313, 2133–2141 (2015).
Zarbock, A. & Kellum, J. A. Remote Ischemic preconditioning and protection of the kidney–a novel therapeutic option. Crit. Care Med. 44, 607–616 (2016).
Kellum, J. A. & Chawla, L. S. Cell-cycle arrest and acute kidney injury: the light and the dark sides. Nephrol. Dial. Transpl. 31, 16–22 (2016).
Katz, N. M., Kellum, J. A. & Ronco, C. Acute kidney stress and prevention of acute kidney Injury. Crit. Care Med. 47, 993–996 (2019).
McCullough, P. A. et al. Serial urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 and the prognosis for acute kidney injury over the course of critical illness. Cardiorenal Med. 9, 358–369 (2019).
Chu, R. et al. Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease. Clin. J. Am. Soc. Nephrol. 9, 1175–1182 (2014).
NIDDK National Institute of Diabetes and Digestive and Kidney Diseases. Kidney Personalized Medicine Project https://www.niddk.nih.gov/research-funding/research-programs/kidney-precision-medicine-project-kpmp (2020).
Wen, X. et al. Time-dependent effects of histone deacetylase inhibition in sepsis-associated acute kidney injury. Intensive Care Med. Exp. 8, 9 (2020).
Husain-Syed, F. et al. Preoperative renal functional reserve predicts risk of acute kidney injury after cardiac operation. Ann. Thorac. Surg. 105, 1094–1101 (2018).
Ferenbach, D. A. & Bonventre, J. V. Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat. Rev. Nephrol. 11, 264–276 (2015).
Kramann, R., Tanaka, M. & Humphreys, B. D. Fluorescence microangiography for quantitative assessment of peritubular capillary changes after AKI in mice. J. Am. Soc. Nephrol. 25, 1924–1931 (2014).
Kane-Gill, S. L., Kirisci, L., Verrico, M. M. & Rothschild, J. M. Analysis of risk factors for adverse drug events in critically ill patients*. Crit. Care Med. 40, 823–828 (2012).
Sawhney, S. et al. Post-discharge kidney function is associated with subsequent ten-year renal progression risk among survivors of acute kidney injury. Kidney Int. 92, 440–452 (2017).
See, E. J. et al. Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney Int. 95, 160–172 (2019).
Stads, S., Fortrie, G., van Bommel, J., Zietse, R. & Betjes, M. G. Impaired kidney function at hospital discharge and long-term renal and overall survival in patients who received CRRT. Clin. J. Am. Soc. Nephrol. 8, 1284–1291 (2013).
Bucaloiu, I. D., Kirchner, H. L., Norfolk, E. R., Hartle, J. E. 2nd & Perkins, R. M. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int. 81, 477–485 (2012).
Rimes-Stigare, C. et al. Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease. Crit. Care 19, 383 (2015).
Brown, J. R., Kramer, R. S., Coca, S. G. & Parikh, C. R. Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann. Thorac. Surg. 90, 1142–1148 (2010).
Fujii, T., Uchino, S., Takinami, M. & Bellomo, R. Subacute kidney injury in hospitalized patients. Clin. J. Am. Soc. Nephrol. 9, 457–461 (2014).
Uchino, S., Bellomo, R., Bagshaw, S. M. & Goldsmith, D. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol. Dial. Transpl. 25, 1833–1839 (2010).
Coca, S. G., King, J. T. Jr., Rosenthal, R. A., Perkal, M. F. & Parikh, C. R. The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int. 78, 926–933 (2010).
Mehta, S. et al. The prognostic importance of duration of AKI: a systematic review and meta-analysis. BMC Nephrol. 19, 91 (2018).
Federspiel, C. K. et al. Duration of acute kidney injury in critically ill patients. Ann. Intensive Care 8, 30 (2018).
Heung, M. et al. Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of veterans health administration data. Am. J. Kidney Dis. 67, 742–752 (2016).
Ravn, B., Prowle, J. R., Martensson, J., Martling, C. R. & Bell, M. Superiority of serum cystatin C over creatinine in prediction of long-term prognosis at discharge from ICU. Crit. Care Med. 45, e932–e940 (2017).
James, M. T. et al. Incidence and prognosis of acute kidney diseases and disorders using an integrated approach to laboratory measurements in a Universal Health care system. JAMA Netw. Open 2, e191795 (2019).
Chawla, L. S. et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat. Rev. Nephrol. 13, 241–257 (2017).
Ronco, C., Ferrari, F. & Ricci, Z. Recovery after acute kidney injury: a new prognostic dimension of the syndrome. Am. J. Respir. Crit. Care Med. 195, 711–714 (2017).
Srisawat, N. et al. Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia. Kidney Int. 80, 545–552 (2011).
Liangos, O. et al. Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J. Am. Soc. Nephrol. 18, 904–912 (2007).
Parr, S. K. et al. Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury. Kidney Int. 87, 640–648 (2015).
Srisawat, N. & Kellum, J. A. The role of biomarkers in acute kidney injury. Crit. Care Clin. 36, 125–140 (2020).
Albert, C. et al. Neutrophil gelatinase-associated lipocalin measured on clinical laboratory platforms for the prediction of acute kidney injury and the associated need for dialysis therapy: a systematic review and meta-analysis. Am. J. Kidney Dis. 76, 826–841 e821 (2020).
Luft, F. C. Biomarkers and predicting acute kidney injury. Acta Physiol. 231, e13479 (2021).
Ostermann, M. et al. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement. JAMA Netw. Open 3, e2019209 (2020).
Al-Jaghbeer, M., Dealmeida, D., Bilderback, A., Ambrosino, R. & Kellum, J. A. Clinical decision support for in-hospital AKI. J. Am. Soc. Nephrol. 29, 654–660 (2018).
Selby, N. M. et al. An organizational-level program of intervention for AKI: a pragmatic stepped wedge cluster randomized trial. J. Am. Soc. Nephrol. 30, 505–515 (2019).
Ostermann, M. et al. Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney Int. 98, 294–309 (2020).
Yamamoto, T. et al. Renal L-type fatty acid–binding protein in acute ischemic injury. J. Am. Soc. Nephrol. 18, 2894–2902 (2007).
Yasuda, K., Nakanishi, K. & Tsutsui, H. Interleukin-18 in health and disease. Int. J. Mol. Sci. 20, 649 (2019).
Gravestein, L. A. & Borst, J. Tumor necrosis factor receptor family members in the immune system. Semin. Immunol. 10, 423–434 (1998).
Venturi, S. & Venturi, M. Iodine in evolution of salivary glands and in oral health. Nutr. Health 20, 119–134 (2009).
Lau, W. H., Leong, W. S., Ismail, Z. & Gam, L. H. Qualification and application of an ELISA for the determination of Tamm Horsfall protein (THP) in human urine and its use for screening of kidney stone disease. Int. J. Biol. Sci. 4, 215–222 (2008).
Kunz, L. I. et al. Regulation of YKL-40 expression by corticosteroids: effect on pro-inflammatory macrophages in vitro and its modulation in COPD in vivo. Respir. Res. 16, 154 (2015).
Hoste, E. et al. Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study. Intensive Care Med. 46, 943–953 (2020).
Schulz-Knappe, P. et al. HCC-1, a novel chemokine from human plasma. J. Exp. Med. 183, 295–299 (1996).
Ronco, C. Nefrologia Medica 2nd edn. (Piccin, 2021).
Author information
Authors and Affiliations
Contributions
All authors researched data for the article, made substantial contributions to discussions of the content, wrote the manuscript, and reviewed or edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
J.A.K. discloses consulting fees and grant support from Baxter, bioMerieux/Astute Medical and Bioporto. R.B. discloses grant support from Ortho Diagnostics and speaking fees from bioMérieux. C.R. discloses consulting fees from Baxter, and speaking fees from Ortho Diagnostics, bioMérieux and Bioporto.
Additional information
Peer review information
Nature Reviews Nephrology thanks the anonymous reviewers for their contribution to the peer review of this work.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Kellum, J.A., Ronco, C. & Bellomo, R. Conceptual advances and evolving terminology in acute kidney disease. Nat Rev Nephrol 17, 493–502 (2021). https://doi.org/10.1038/s41581-021-00410-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41581-021-00410-w
This article is cited by
-
Trajectory pattern of serially measured acute kidney injury biomarkers in critically ill patients: a prospective observational study
Annals of Intensive Care (2024)
-
STING contributes to lipopolysaccharide-induced tubular cell inflammation and pyroptosis by activating endoplasmic reticulum stress in acute kidney injury
Cell Death & Disease (2024)
-
Development of a new miniaturized system for ultrafiltration
Heart Failure Reviews (2024)
-
Urinary neutrophil gelatinase-associated lipocalin and plasma IL-6 in discontinuation of continuous venovenous hemodiafiltration for severe acute kidney injury: a multicenter prospective observational study
Annals of Intensive Care (2023)
-
Acute kidney injury in neurocritical care
Critical Care (2023)